Analyzing 5N Plus (OTCMKTS:FPLSF) and Amplifon (OTCMKTS:AMFPF)

Amplifon (OTCMKTS:AMFPF) and 5N Plus (OTCMKTS:FPLSF) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, valuation, dividends, earnings, analyst recommendations, institutional ownership and risk.

Profitability

This table compares Amplifon and 5N Plus’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Amplifon	7.44%	16.57%	4.83%
5N Plus	6.35%	7.61%	2.72%

Volatility & Risk

Amplifon has a beta of 0.42, indicating that its share price is 58% less volatile than the S&P 500. Comparatively, 5N Plus has a beta of 1.82, indicating that its share price is 82% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current recommendations for Amplifon and 5N Plus, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Amplifon	0	0	2	0	3.00
5N Plus	0	0	0	0	N/A

5N Plus has a consensus price target of $5.50, suggesting a potential upside of 60.82%. Given 5N Plus’ higher probable upside, analysts clearly believe 5N Plus is more favorable than Amplifon.

Institutional & Insider Ownership

0.1% of 5N Plus shares are held by institutional investors. 3.9% of 5N Plus shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Earnings & Valuation

This table compares Amplifon and 5N Plus’ revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Amplifon	$2.23 billion	N/A	$188.09 million	$0.78	41.28
5N Plus	$242.37 million	1.25	$15.40 million	$0.18	19.00

Amplifon has higher revenue and earnings than 5N Plus. 5N Plus is trading at a lower price-to-earnings ratio than Amplifon, indicating that it is currently the more affordable of the two stocks.

Summary

Amplifon beats 5N Plus on 8 of the 12 factors compared between the two stocks.

About Amplifon

Amplifon S.p.A. engages in the distribution of hearing solutions and the fitting of customized products that help people rediscover various emotions of sound in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company offers Ampli-easy, Ampli-connect, Ampli-energy, and Ampli-mini hearing devices. It also operates Ampli-care, a platform to deliver audiological care experience; and Amplifon App to manage the device functions in real-time directly from smartphone. Amplifon S.p.A. was founded in 1950 and is headquartered in Milan, Italy. Amplifon S.p.A.

About 5N Plus

5N Plus Inc. produces and sells specialty metals and chemicals in North America, Europe, and Asia. It operates through two segments, Specialty Semiconductors and Performance Materials. The company offers semiconductor compounds, semiconductor wafers, metals, epitaxial semiconductor substrates, and solar cells. It also provides active pharmaceutical ingredients, animal feed additives, specialized chemicals, commercial grade metals, alloys, engineered powders, and recycling services. The company serves renewable energy, security, space, pharmaceutical, medical imaging, manufacturing, electronic, consumer, and industrial application markets. 5N Plus Inc. is headquartered in Montreal, Canada.